LEXICON PHARMACEUTICALS, INC. Increase (Decrease) in Accounts Receivable
LEXICON PHARMACEUTICALS, INC. (LXRX) reported Increase (Decrease) in Accounts Receivable of -$741.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-06
- LEXICON PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$10.14M.
- LEXICON PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $9.39M.
- LEXICON PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $50.00K, a 91.35% decline year-over-year.
- LEXICON PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $151.00K, a 45.09% decline year-over-year.
- LEXICON PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for fiscal 2025 was -$1.09M, a 144.21% decline from fiscal 2024.
- LEXICON PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for fiscal 2024 was $2.46M, a 150.81% increase from fiscal 2023.
- LEXICON PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for fiscal 2023 was $982.00K, a 6914.29% increase from fiscal 2022.
- LEXICON PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for fiscal 2022 was $14.00K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$10.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$741.00K 10-Q · filed 2026-08-06 | -$691.00K derived: sum of 3 quarters · filed 2026-08-06 | -$540.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $9.39M 10-Q · filed 2026-05-07 | $9.45M derived: sum of 2 quarters · filed 2026-05-07 | $9.60M derived: sum of 3 quarters · filed 2026-05-07 | $9.33M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $201.00K derived: sum of 2 quarters · filed 2026-03-05 | -$63.00K derived: sum of 3 quarters · filed 2026-08-06 | -$1.09M 10-K · filed 2026-03-05 |
| 2025-09-30 | $151.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$113.00K derived: sum of 2 quarters · filed 2026-08-06 | -$1.14M 10-Q · filed 2025-11-06 | -$561.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$264.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.29M 10-Q · filed 2026-08-06 | -$712.00K derived: sum of 3 quarters · filed 2026-08-06 | -$437.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$1.03M 10-Q · filed 2026-05-07 | -$448.00K derived: sum of 2 quarters · filed 2026-05-07 | -$173.00K derived: sum of 3 quarters · filed 2026-05-07 | $921.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $578.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $853.00K derived: sum of 2 quarters · filed 2026-03-05 | $1.95M derived: sum of 3 quarters · filed 2026-03-05 | $2.46M 10-K · filed 2026-03-05 |
| 2024-09-30 | $275.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.37M derived: sum of 2 quarters · filed 2025-11-06 | $1.89M 10-Q · filed 2025-11-06 | $2.58M derived: sum of 4 quarters · filed 2026-03-05 |
| 2024-06-30 | $1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $1.61M 10-Q · filed 2025-08-06 | $2.30M derived: sum of 3 quarters · filed 2026-03-05 | $1.94M derived: sum of 4 quarters · filed 2026-03-05 |
| 2024-03-31 | $516.00K 10-Q · filed 2025-05-14 | $1.21M derived: sum of 2 quarters · filed 2026-03-05 | $841.00K derived: sum of 3 quarters · filed 2026-03-05 | $1.26M derived: sum of 4 quarters · filed 2026-03-05 |
| 2023-12-31 | $692.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $325.00K derived: sum of 2 quarters · filed 2026-03-05 | $748.00K derived: sum of 3 quarters · filed 2026-03-05 | $982.00K 10-K · filed 2026-03-05 |
| 2023-09-30 | -$367.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $56.00K derived: sum of 2 quarters · filed 2024-11-13 | $290.00K 10-Q · filed 2024-11-13 | $278.00K derived: sum of 4 quarters · filed 2025-03-07 |
| 2023-06-30 | $423.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $657.00K 10-Q · filed 2024-08-02 | $645.00K derived: sum of 3 quarters · filed 2025-03-07 | $651.00K derived: sum of 4 quarters · filed 2025-03-07 |
| 2023-03-31 | $234.00K 10-Q · filed 2024-05-02 | $222.00K derived: sum of 2 quarters · filed 2025-03-07 | $228.00K derived: sum of 3 quarters · filed 2025-03-07 | $225.00K derived: sum of 4 quarters · filed 2025-03-07 |
| 2022-12-31 | -$12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | -$6.00K derived: sum of 2 quarters · filed 2025-03-07 | -$9.00K derived: sum of 3 quarters · filed 2025-03-07 | $14.00K 10-K · filed 2025-03-07 |
| 2022-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $3.00K derived: sum of 2 quarters · filed 2023-11-08 | $26.00K 10-Q · filed 2023-11-08 | $17.00K derived: sum of 4 quarters · filed 2024-03-25 |
| 2022-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $20.00K 10-Q · filed 2023-08-04 | $11.00K derived: sum of 3 quarters · filed 2024-03-25 | -$125.00K derived: sum of 4 quarters · filed 2024-03-25 |
| 2022-03-31 | $23.00K 10-Q · filed 2023-05-04 | $14.00K derived: sum of 2 quarters · filed 2024-03-25 | -$122.00K derived: sum of 3 quarters · filed 2024-03-25 | -$64.00K derived: sum of 4 quarters · filed 2024-03-25 |
| 2021-12-31 | -$9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | -$145.00K derived: sum of 2 quarters · filed 2024-03-25 | -$87.00K derived: sum of 3 quarters · filed 2024-03-25 | -$381.00K 10-K · filed 2024-03-25 |
| 2021-09-30 | -$136.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$78.00K derived: sum of 2 quarters · filed 2022-11-09 | -$372.00K 10-Q · filed 2022-11-09 | -$1.40M derived: sum of 4 quarters · filed 2023-03-03 |
| 2021-06-30 | $58.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$236.00K 10-Q · filed 2022-08-03 | -$1.26M derived: sum of 3 quarters · filed 2023-03-03 | -$27.81M derived: sum of 4 quarters · filed 2023-03-03 |
| 2021-03-31 | -$294.00K 10-Q · filed 2022-05-05 | -$1.32M derived: sum of 2 quarters · filed 2023-03-03 | -$27.86M derived: sum of 3 quarters · filed 2023-03-03 | -$27.12M derived: sum of 4 quarters · filed 2023-03-03 |
| 2020-12-31 | -$1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | -$27.57M derived: sum of 2 quarters · filed 2023-03-03 | -$26.83M derived: sum of 3 quarters · filed 2023-03-03 | -$53.23M 10-K · filed 2023-03-03 |
| 2020-09-30 | -$26.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$25.80M derived: sum of 2 quarters · filed 2021-11-09 | -$52.20M 10-Q · filed 2021-11-09 | -$52.51M derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-06-30 | $741.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | -$25.66M 10-Q · filed 2021-08-06 | -$25.96M derived: sum of 3 quarters · filed 2022-03-10 | $25.30M derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-03-31 | -$26.40M 10-Q · filed 2021-05-06 | -$26.71M derived: sum of 2 quarters · filed 2022-03-10 | $24.55M derived: sum of 3 quarters · filed 2022-03-10 | $25.75M derived: sum of 4 quarters · filed 2022-03-10 |
| 2019-12-31 | -$309.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $50.95M derived: sum of 2 quarters · filed 2022-03-10 | $52.14M derived: sum of 3 quarters · filed 2022-03-10 | $50.61M 10-K · filed 2022-03-10 |
| 2019-09-30 | $51.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | $52.45M derived: sum of 2 quarters · filed 2020-10-30 | $50.92M 10-Q · filed 2020-10-30 | $53.93M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-06-30 | $1.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | -$344.00K 10-Q · filed 2020-07-29 | $2.67M derived: sum of 3 quarters · filed 2021-03-12 | $1.17M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-03-31 | -$1.53M 10-Q · filed 2020-04-27 | $1.48M derived: sum of 2 quarters · filed 2021-03-12 | -$16.00K derived: sum of 3 quarters · filed 2021-03-12 | -$92.00K derived: sum of 4 quarters · filed 2021-03-12 |
| 2018-12-31 | $3.01M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $1.52M derived: sum of 2 quarters · filed 2021-03-12 | $1.44M derived: sum of 3 quarters · filed 2021-03-12 | $1.10M 10-K · filed 2021-03-12 |
| 2018-09-30 | -$1.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$1.57M derived: sum of 2 quarters · filed 2019-11-07 | -$1.91M 10-Q · filed 2019-11-07 | -$5.18M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | -$76.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$419.00K 10-Q · filed 2019-08-01 | -$3.69M derived: sum of 3 quarters · filed 2020-03-12 | $1.89M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | -$343.00K 10-Q · filed 2019-05-01 | -$3.61M derived: sum of 2 quarters · filed 2020-03-12 | $1.97M derived: sum of 3 quarters · filed 2020-03-12 | -$1.75M derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | -$3.27M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $2.31M derived: sum of 2 quarters · filed 2020-03-12 | -$1.41M derived: sum of 3 quarters · filed 2020-03-12 | -$166.00K 10-K · filed 2020-03-12 |
| 2017-09-30 | $5.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $1.86M derived: sum of 2 quarters · filed 2018-11-01 | $3.10M 10-Q · filed 2018-11-01 | $7.36M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-06-30 | -$3.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-30 | -$2.48M 10-Q · filed 2018-07-30 | $1.77M derived: sum of 3 quarters · filed 2019-03-15 | $1.50M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-03-31 | $1.24M 10-Q · filed 2018-05-03 | $5.49M derived: sum of 2 quarters · filed 2019-03-15 | $5.21M derived: sum of 3 quarters · filed 2019-03-15 | $5.49M derived: sum of 4 quarters · filed 2019-03-15 |
| 2016-12-31 | $4.25M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $3.97M derived: sum of 2 quarters · filed 2019-03-15 | $4.25M derived: sum of 3 quarters · filed 2019-03-15 | $4.08M 10-K · filed 2019-03-15 |
| 2016-09-30 | -$280.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$3.00K derived: sum of 2 quarters · filed 2017-11-08 | -$173.00K 10-Q · filed 2017-11-08 | $666.00K derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | $277.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $107.00K 10-Q · filed 2017-08-01 | $946.00K derived: sum of 3 quarters · filed 2018-03-01 | $702.00K derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | -$170.00K 10-Q · filed 2017-05-04 | $669.00K derived: sum of 2 quarters · filed 2018-03-01 | $425.00K derived: sum of 3 quarters · filed 2018-03-01 | $571.00K derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | $839.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $595.00K derived: sum of 2 quarters · filed 2018-03-01 | $741.00K derived: sum of 3 quarters · filed 2018-03-01 | -$124.00K 10-K · filed 2018-03-01 |
| 2015-09-30 | -$244.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$98.00K derived: sum of 2 quarters · filed 2016-11-07 | -$963.00K 10-Q · filed 2016-11-07 | -$795.00K derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-06-30 | $146.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$719.00K 10-Q · filed 2016-08-04 | -$551.00K derived: sum of 3 quarters · filed 2017-03-06 | -$667.00K derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-03-31 | -$865.00K 10-Q · filed 2016-05-05 | -$697.00K derived: sum of 2 quarters · filed 2017-03-06 | -$813.00K derived: sum of 3 quarters · filed 2017-03-06 | -$1.00M derived: sum of 4 quarters · filed 2017-03-06 |
| 2014-12-31 | $168.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $52.00K derived: sum of 2 quarters · filed 2017-03-06 | -$138.00K derived: sum of 3 quarters · filed 2017-03-06 | -$457.00K 10-K · filed 2017-03-06 |
| 2014-09-30 | -$116.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$306.00K derived: sum of 2 quarters · filed 2015-11-09 | -$625.00K 10-Q · filed 2015-11-09 | -$730.00K derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-06-30 | -$190.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$509.00K 10-Q · filed 2015-08-07 | -$614.00K derived: sum of 3 quarters · filed 2016-03-11 | -$733.00K derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-03-31 | -$319.00K 10-Q · filed 2015-05-05 | -$424.00K derived: sum of 2 quarters · filed 2016-03-11 | -$543.00K derived: sum of 3 quarters · filed 2016-03-11 | -$392.00K derived: sum of 4 quarters · filed 2016-03-11 |
| 2013-12-31 | -$105.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | -$224.00K derived: sum of 2 quarters · filed 2016-03-11 | -$73.00K derived: sum of 3 quarters · filed 2016-03-11 | -$588.00K 10-K · filed 2016-03-11 |
| 2013-09-30 | -$119.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $32.00K derived: sum of 2 quarters · filed 2014-11-06 | -$483.00K 10-Q · filed 2014-11-06 | $662.00K derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-06-30 | $151.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$364.00K 10-Q · filed 2014-08-07 | $781.00K derived: sum of 3 quarters · filed 2015-03-12 | $832.00K derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-03-31 | -$515.00K 10-Q · filed 2014-05-08 | $630.00K derived: sum of 2 quarters · filed 2015-03-12 | $681.00K derived: sum of 3 quarters · filed 2015-03-12 | $677.00K derived: sum of 4 quarters · filed 2015-03-12 |
| 2012-12-31 | $1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $1.20M derived: sum of 2 quarters · filed 2015-03-12 | $1.19M derived: sum of 3 quarters · filed 2015-03-12 | $1.03M 10-K · filed 2015-03-12 |
| 2012-09-30 | $51.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $47.00K derived: sum of 2 quarters · filed 2013-11-12 | -$117.00K 10-Q · filed 2013-11-12 | -$256.00K derived: sum of 4 quarters · filed 2014-03-07 |
| 2012-06-30 | -$4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | -$168.00K 10-Q · filed 2013-08-01 | -$307.00K derived: sum of 3 quarters · filed 2014-03-07 | -$323.00K derived: sum of 4 quarters · filed 2014-03-07 |
| 2012-03-31 | -$164.00K 10-Q · filed 2013-05-10 | -$303.00K derived: sum of 2 quarters · filed 2014-03-07 | -$319.00K derived: sum of 3 quarters · filed 2014-03-07 | -$645.00K derived: sum of 4 quarters · filed 2014-03-07 |
| 2011-12-31 | -$139.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | -$155.00K derived: sum of 2 quarters · filed 2014-03-07 | -$481.00K derived: sum of 3 quarters · filed 2014-03-07 | -$394.00K 10-K · filed 2014-03-07 |
| 2011-09-30 | -$16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | -$342.00K derived: sum of 2 quarters · filed 2012-11-07 | -$255.00K 10-Q · filed 2012-11-07 | -$851.00K derived: sum of 4 quarters · filed 2013-03-11 |
| 2011-06-30 | -$326.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | -$239.00K 10-Q · filed 2012-08-02 | -$835.00K derived: sum of 3 quarters · filed 2013-03-11 | -$1.58M derived: sum of 4 quarters · filed 2013-03-11 |
| 2011-03-31 | $87.00K 10-Q · filed 2012-05-03 | -$509.00K derived: sum of 2 quarters · filed 2013-03-11 | -$1.25M derived: sum of 3 quarters · filed 2013-03-11 | |
| 2010-12-31 | -$596.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | -$1.34M derived: sum of 2 quarters · filed 2013-03-11 | -$488.00K 10-K · filed 2013-03-11 | |
| 2010-09-30 | -$743.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-01 | $108.00K 10-Q · filed 2011-11-01 | ||
| 2010-06-30 | $851.00K 10-Q · filed 2011-08-09 | |||
| 2009-12-31 | $247.00K 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |